# Memantine for Neuroprotection and Cognitive Enhancement Following Traumatic Brain Injury

> **NCT02240589** · NA · COMPLETED · sponsor: **Indiana University** · enrollment: 11 (actual)

## Conditions studied

- Traumatic Brain Injury

## Interventions

- **DRUG:** Memantine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02240589
- **Lead sponsor:** Indiana University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-12
- **Primary completion:** 2016-04
- **Final completion:** 2016-04
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2017-08-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02240589

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02240589, "Memantine for Neuroprotection and Cognitive Enhancement Following Traumatic Brain Injury". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02240589. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*